Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal apoptosis is the tightly regulated process of programmed cell death in neurons; it involves the activation of molecular pathways (e.g., caspases) that dismantle cellular components in an orderly manner and is crucial for removing surplus or damaged neurons during development and throughout life[1][2]. Dysregulation of neuronal apoptosis can contribute to neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases, as well as to developmental disorders and injuries[1][2][3]. Molecular triggers include internal signals (DNA damage, loss of survival factors) and external signals (activation of death receptors such as Fas or TNF receptor)[5]. Detectable by biomarkers such as caspase activation and DNA fragmentation, neuronal apoptosis is essential for brain health but is not a therapeutic target itself; rather, its molecular mediators (e.g., caspases, apoptosis-inducing factor) may serve as drug targets[2][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal apoptosis.